Drivers of chronic rhinosinusitis: Inflammation versus infection

Slides:



Advertisements
Similar presentations
Innate Immunity (part 1) BIOS 486A/586A
Advertisements

Modulation of Gene Expression via Disruption Of NF-kB Signaling by a
Peter J. Barnes, FRS, FMedSci 
Inflamm Intest Dis 2016;1: DOI: /
Monoclonal antibodies and fusion proteins in medicine
Innate Immune Response (Ch14)
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Innate microbial sensors and their relevance to allergy
Natalija Novak, MD  Journal of Allergy and Clinical Immunology 
Basophils and allergic inflammation
Endotype-driven care pathways in patients with chronic rhinosinusitis
IL-17–producing T cells in lung immunity and inflammation
Donald Y.M. Leung, MD, PhD, Emma Guttman-Yassky, MD, PhD 
Host-microbial interactions in patients with chronic rhinosinusitis
The role of viruses in acute exacerbations of asthma
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Peter J. Barnes, FRS, FMedSci 
Microbial Influences in Inflammatory Bowel Diseases
Gut Microbiota: Mining for Therapeutic Potential
Dendritic cells: Bridging innate and adaptive immunity in atopic dermatitis  Natalija Novak, MD, Susanne Koch, PhD, Jean-Pierre Allam, MD, Thomas Bieber,
Minyoung Her, MD, Arthur Kavanaugh, MD 
Peter J. Barnes, FMedSci, FRS 
Therapeutic pipeline for atopic dermatitis: End of the drought?
Jennifer L. Ingram, PhD, Monica Kraft, MD 
Shinji Noda, MD, PhD, James G
Histamine in the immune regulation of allergic inflammation
Control of immunopathology during chikungunya virus infection
Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence  M.G. Netea, J.W.M.
The National Biome Initiative: An allergy perspective
The 3 major types of innate and adaptive cell-mediated effector immunity  Francesco Annunziato, PhD, Chiara Romagnani, MD, PhD, Sergio Romagnani, MD  Journal.
Daniel L. Hamilos, MD  Journal of Allergy and Clinical Immunology 
Cross-talk between human mast cells and epithelial cells by IgE-mediated periostin production in eosinophilic nasal polyps  Dae Woo Kim, MD, PhD, Marianna.
Advances in atopic dermatitis and urticarial in 2016
Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor–dependent innate antiviral immune responses  Douglas R. McDonald, MD, PhD,
TH17 and TH22 cells: A confusion of antimicrobial response with tissue inflammation versus protection  Mübeccel Akdis, MD, PhD, Oscar Palomares, PhD,
Inflammatory health effects of indoor and outdoor particulate matter
Innate lymphoid cells in allergic and nonallergic inflammation
Epithelium: At the interface of innate and adaptive immune responses
蔡易錚 MD. PhD. 新光醫院耳鼻喉科 輔仁大學醫學系
Bridging immunity and lipid metabolism by gut microbiota
F.L. van de Veerdonk, B.-J. Kullberg, M.G. Netea 
Current and Future Treatment of Peanut Allergy
Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted/CCL5.
Human innate lymphoid cells
Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species  László Maródi, MD, PhD, Sophie Cypowyj, PhD, Beáta Tóth, PhD,
Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response
TGF-β1: Mediator of a feedback loop in eosinophilic esophagitis—or should we really say mastocytic esophagitis?  J. Pablo Abonia, MD, James P. Franciosi,
Karin R. Engelhardt, Dr rer nat, Bodo Grimbacher, MD 
The role of the T cell in asthma
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
The eosinophil—quo vadis?
The skin as an immune organ: Tolerance versus effector responses and applications to food allergy and hypersensitivity reactions  Emma Guttman-Yassky,
Chronic rhinosinusitis pathogenesis
Cytokines and chemokines orchestrate atopic skin inflammation
Mechanisms of food allergy
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Peter J. Barnes, DM, DSc, FRCP 
Sachin K. Samuchiwal, PhD, Joshua A. Boyce, MD 
Claus Bachert, MD, PhD, Luo Zhang, MD, Phillippe Gevaert, MD 
Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness  Michael R. Edwards, PhD, Katherine Strong,
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Innate lymphoid cells in allergic and nonallergic inflammation
Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy.
Peter J. Barnes, FRS, FMedSci 
Molecular and cellular mechanisms of food allergy and food tolerance
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts  Emma Guttman-Yassky, MD, PhD, Kristine.
The future of biologics: Applications for food allergy
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
Airway smooth muscle: An immunomodulatory cell
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Drivers of chronic rhinosinusitis: Inflammation versus infection Daniel L. Hamilos, MD  Journal of Allergy and Clinical Immunology  Volume 136, Issue 6, Pages 1454-1459 (December 2015) DOI: 10.1016/j.jaci.2015.10.011 Copyright © 2015 Terms and Conditions

Fig 1 Drivers of “infectious” inflammation in patients with CRS. There is evidence for an association between bacterial biofilm and “dysbiosis” of the normal sinus microbiome and persistent infectious (neutrophilic) inflammation in patients with CRS. To date, the best described deficiencies in innate immunity associated with CRS are a deficiency in mucosal lactoferrin production3,4 and a genetic polymorphism in the bitter taste receptor gene TAS2R38,5 which results in a loss-of-function receptor leading to an inability to sense a quorum-sensing molecule elaborated by Pseudomonas aeruginosa and generate normal antimicrobial nitric oxide (NO) levels. In contrast, no primary defects in other epithelial pattern recognition receptors (eg, TLRs or NOD receptors) have been described in patients with CRS. Antimicrobial peptides produced in epithelial cells include (among others) lactoferrin, defensins (human b-defensin 2), cathelicidins, and PLUNC proteins. AC, Adenylate cyclase. The bitter taste receptor is a G-protein coupled receptor. Journal of Allergy and Clinical Immunology 2015 136, 1454-1459DOI: (10.1016/j.jaci.2015.10.011) Copyright © 2015 Terms and Conditions

Fig 2 Drivers of maladaptive TH2 inflammation and augmentation of TH2 immune responses by innate inflammatory cytokines from dysregulated epithelial cells in patients with CRSwNP. The local tissue inflammatory response in patients with CRSwNP is strongly biased toward eosinophilic TH2 inflammation, often despite a lack of systemic evidence for allergic disease.6 Staphylococcus aureus can serve as a microbial driver for maladaptive TH2 inflammation in patients with CRSwNP by virtue of staphylococcal superantigen–induced local T-lymphocyte stimulation and production of superantigen-specific IgE.7-11 T lymphocytes in NPs are skewed toward enrichment for Vβ elements that are known to respond to staphylococcal superantigens,10-12 and SEB induces robust production of IL-5 and IL-13 in dispersed NP T lymphocytes.13 Certain fungi, particularly Alternaria and Candida species, induce production of IL-5 and IL-13, as well as IFN-γ, in peripheral blood lymphocytes from patients with CRS and might therefore also serve as a driver for the local TH2 inflammatory response.14 A alternata might also drive innate TH2 inflammation mediated through IL-33 and innate TH2 lymphocytes.15 Dysregulated epithelial proinflammatory factor production, including overproduction of IL-25, TSLP, and C-C chemokines, also serves to drive TH2 inflammation in patients with CRSwNP independent of TH2 adaptive immunity. The underlying drivers of these TH2 proinflammatory signals in patients with CRSwNP remain unclear. Adapted from Hamilos.16 Journal of Allergy and Clinical Immunology 2015 136, 1454-1459DOI: (10.1016/j.jaci.2015.10.011) Copyright © 2015 Terms and Conditions